Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
JAMA Neurol 2020 Sep 01;77(9)1099-1109, S Craft, R Raman, TW Chow, MS Rafii, CK Sun, RA Rissman, MC Donohue, JB Brewer, C Jenkins, K Harless, D Gessert, PS AisenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.